Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Optimized Treatment”

314 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 314 results

Large-scale testing (Phase 3)Study completedNCT01910987
What this trial is testing

Study to Evaluate Optimized Retreatment and Prolonged Therapy With Bortezomib

Who this might be right for
Multiple Myeloma
Janssen-Cilag International NV 80
Post-approval studies (Phase 4)Study completedNCT03985514
What this trial is testing

Acute Appendicitis: Active Observation With and Without Antibiotics

Who this might be right for
Appendicitis
Göteborg University 126
Testing effectiveness (Phase 2)Study completedNCT03690921
What this trial is testing

Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial

Who this might be right for
Anal Canal Squamous Cell CarcinomaStage I Anal Cancer AJCC v8Stage II Anal Cancer AJCC v8+6 more
M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Study completedNCT00105157
What this trial is testing

Safety and Efficacy of an Investigational Drug in Human Immunodeficiency Virus (HIV)-Infected Patients Failing Current Antiretroviral Therapies (0518-005)(COMPLETED)

Who this might be right for
HIV InfectionsAcquired Immunodeficiency Syndrome
Merck Sharp & Dohme LLC 179
Testing effectiveness (Phase 2)Study completedNCT00243230
What this trial is testing

Vicriviroc (SCH 417690) in Combination Treatment With Optimized ART Regimen in Experienced Participants (VICTOR-E1) (MK-7690-020/P03672)

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 116
Early research (Phase 1)Study completedNCT01856634
What this trial is testing

Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis

Who this might be right for
Multidrug Resistant TuberculosisPediatric
Otsuka Pharmaceutical Development & Commercialization, Inc. 37
Not applicableLooking for participantsNCT07486206
What this trial is testing

Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial

Who this might be right for
Interstitial Lung Disease (ILD)Fibrotic Interstitial Lung DiseaseIdiopathic Pulmonary Fibrosis (IPF)+2 more
Hospital de Granollers 152
Testing effectiveness (Phase 2)Study completedNCT00551330
What this trial is testing

Vicriviroc in HIV(R5/X4)-Treatment Experienced Subjects (Study P05057AM5)(COMPLETED)

Who this might be right for
HIV InfectionsAcquired Immunodeficiency Syndrome
Merck Sharp & Dohme LLC 111
Testing effectiveness (Phase 2)Study completedNCT02396134
What this trial is testing

Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+11 more
City of Hope Medical Center 61
Large-scale testing (Phase 3)Study completedNCT01337089
What this trial is testing

Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Who this might be right for
PainAdvanced Cancer
Jazz Pharmaceuticals 660
Testing effectiveness (Phase 2)Looking for participantsNCT06977074
What this trial is testing

PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLC

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Sun Yat-sen University 83
Testing effectiveness (Phase 2)UnknownNCT00082862
What this trial is testing

Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
The University of Texas Health Science Center, Houston 48
Post-approval studies (Phase 4)Study completedNCT02130674
What this trial is testing

Optimized Therapy in Severe Traumatic Brain Injured Patients

Who this might be right for
Traumatic Brain InjuryComa
University of Zurich 12
Not applicableUnknownNCT04570514
What this trial is testing

Optimized Cardioprotection Therapy in Obese Subjects With AMI

Who this might be right for
Acute Myocardial InfarctionMyocardial Reperfusion InjuryObesity+1 more
Xijing Hospital 120
Testing effectiveness (Phase 2)Study completedNCT03444038
What this trial is testing

Open-Label Safety and Tolerability Study of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome

Who this might be right for
Tourette Syndrome
Neurocrine Biosciences 85
Not applicableStudy completedNCT03451734
What this trial is testing

Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients

Who this might be right for
SchizophreniaMetabolic Syndrome
Central South University 2,000
Not applicableLooking for participantsNCT07833696
What this trial is testing

Characteristics and Management of Patients With Severe Chronic Spontaneous and/or Inducible Urticaria Refractory to Optimized Omalizumab Treatment: A French Multicenter Observational Study.

Who this might be right for
Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU)
Centre Hospitalier Universitaire de Besancon 73
Large-scale testing (Phase 3)Study completedNCT01478542
What this trial is testing

OPTIMAL>60 / DR. CHOP, Improvement of Therapy of Elderly Patients with CD20+ DLBCL Using Rituximab Optimized and Liposomal Vincristine

Who this might be right for
CD20+ Aggressive B-Cell Lymphoma
Universität des Saarlandes 1,152
Testing effectiveness (Phase 2)Study completedNCT03489291
What this trial is testing

Dose Confirmation Trial of AAV5-hFIXco-Padua

Who this might be right for
Hemophilia B
CSL Behring 3
Not applicableStudy completedNCT01623778
What this trial is testing

Optimization of Antiviral Therapy of Chronic HBV Infection

Who this might be right for
Australia Antigen PositiveHepatitis BAdverse Effects
Changhai Hospital 67
Next Page